Press Releases Crossject

Equities

ALCJ

FR0011716265

Market Closed - Euronext Paris Other stock markets 09:05:20 28/06/2024 pm IST			5-day change	1st Jan Change
1.626 ^EUR	-6.44%		-3.79%	-67.28%

13/06	Crossject SA Announces the Appointment of Dan Chiche as Chief Medical Officer North America	CI
05/06	Crossject: successful capital increase	CF

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Crossject elaborates on ZEPIZURE potential in light of landmark RAMPART study and its own, recently published, bioequivalence study	27/06	AQ
Crossject elaborates on ZEPIZURE® potential in light of landmark RAMPART study and its own, recently published, bioequivalence study	26/06	GL
Crossject appoints Dan Chiche, MD as Chief Medical Officer North America	12/06	GL
Crossject appoints Dan Chiche, MD as Chief Medical Officer North America	12/06	AQ
Crossject announces highly successful closing of its €8 million rights offering	04/06	GL
Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy	30/05	GL
Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe	02/05	GL
Crossject reports audited financial results for 2023	25/04	GL
Crossject trading on Euronext to resume as usual on Wednesday April 3	02/04	GL
Crossject advances in its U.S. Strategy and reports Financial Results for 2023	02/04	GL
Crossject gender equality score reaches 96/100 in 2024	08/03	GL
Crossject gender equality score reaches 96/100 in 2024	08/03	AQ
Crossject obtains a financing up to €12 million, in two tranches	27/02	GL
Crossject obtains a financing up to €12 million, in two tranches	27/02	AQ
Crossject provides strategic update on priorities for 2024	06/02	GL
Crossject provides strategic update on priorities for 2024	06/02	AQ
Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CET	01/02	GL
Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CET	01/02	AQ
Crossject to present at Biotech Showcase on January 9 at 16:30 PT	09/01	GL
Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®	04/01	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Crossject

Equities

ALCJ

FR0011716265

Press Releases

Filters